Home › Neuroendocrine Tumors › Connecticut › New Haven
Neuroendocrine Tumors clinical trials in New Haven, CT
3 studies for Neuroendocrine Tumors are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RecruitingPhase 3
- Yale University - New Haven Hospital - Yale Cancer Center, New Haven
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Yale University, New Haven
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, New Haven
Neuroendocrine Tumors trials in other cities
- Philadelphia, PA11 studies
- Washington, DC11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- St. Louis, MO8 studies
- Columbus, OH8 studies
- Salt Lake City, UT8 studies
- Lexington, KY7 studies
- Cedar Rapids, IA7 studies
- Cleveland, OH7 studies
- New York City, NY7 studies
- Chicago, IL7 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)34 studies
- Lung Cancer23 studies
- Metastatic Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Prostate Cancer21 studies
- Colorectal Cancer21 studies
- Ovarian Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.